We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$759B
AUM Growth
+$62.2B
Cap. Flow
+$8.76B
Cap. Flow %
1.15%
Top 10 Hldgs %
15.99%
Holding
7,423
New
754
Increased
2,939
Reduced
2,285
Closed
593
Avg Time Held Equity + Options
17.2 quarters
Top 10 Avg Time Held Equity + Options
15.7 quarters
Top 20 Avg Time Held Equity + Options
12.9 quarters
Avg Time Held Equity only
18.8 quarters
Top 10 Avg Time Held Equity only
15.7 quarters
Top 20 Avg Time Held Equity only
15.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.19%
2 Technology 14.28%
3 Healthcare 12.84%
4 Financials 10.61%
5 Consumer Discretionary 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VKTX icon
5951
Viking Therapeutics
VKTX
$3.73B
$4K ﹤0.01%
498
-28,510
-98% -$127K
2018 Q2
18 quarters
WDIV icon
5952
State Street SPDR S&P Global Dividend ETF
WDIV
$276M
$4K ﹤0.01%
67
+40
+148% +$2.28K
2014 Q3
33 quarters
ZVRA icon
5953
Zevra Therapeutics
ZVRA
$607M
$4K ﹤0.01%
778
-1,397
-64% -$7.09K
2021 Q2
6 quarters
PRLHW
5954
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
– –
0
– –
2022 Q2
2 quarters
AUMN
5955
DELISTED
Golden Minerals Company
AUMN
$4K ﹤0.01%
600
-3
-0.5% -$20
2013 Q2
38 quarters
IRAAW
5956
DELISTED
Iris Acquisition Corp Warrant
IRAAW
– –
0
– –
2022 Q1
3 quarters
DLA
5957
DELISTED
Delta Apparel Inc.
DLA
$4K ﹤0.01%
364
-161
-31% -$2.19K
2017 Q4
20 quarters
NTCO
5958
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$4K ﹤0.01%
1,005
-257,652
-100% -$1.25M
2020 Q1
11 quarters
RAIN
5959
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$4K ﹤0.01%
452
-235
-34% -$1.48K
2021 Q2
6 quarters
CFIVW
5960
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
– –
0
– –
2022 Q1
3 quarters
ASPY
5961
DELISTED
ASYMmetric Smart S&P 500 ETF
ASPY
$4K ﹤0.01%
+165
New +$4.43K
2022 Q4
0 quarters
LOKM.WS
5962
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
– –
0
– –
2022 Q1
3 quarters
MACK
5963
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4K ﹤0.01%
+354
New +$2.92K
2022 Q4
0 quarters
DISH
5964
PUT
DELISTED
DISH Network Corp.
DISH
$4K ﹤0.01%
300
– –
2022 Q3
1 quarter
RACY
5965
DELISTED
Relativity Acquisition Corp. Class A Common Stock
RACY
$4K ﹤0.01%
+309
New +$3.17K
2022 Q4
0 quarters
AEHR icon
5966
Aehr Test Systems
AEHR
$3.42B
$3K ﹤0.01%
+140
New +$3K
2022 Q4
0 quarters
ALTL icon
5967
Pacer Lunt Large Cap Alternator ETF
ALTL
$84.2M
$3K ﹤0.01%
+82
New +$3.22K
2022 Q4
0 quarters
ANIX icon
5968
Anixa Biosciences
ANIX
$103M
$3K ﹤0.01%
650
– –
2017 Q2
22 quarters
AR icon
5969
PUT
Antero Resources
AR
$10.5B
$3K ﹤0.01%
100
– –
2020 Q4
8 quarters
BTBT icon
5970
Bit Digital
BTBT
$581M
$3K ﹤0.01%
4,830
-579,744
-99% -$541K
2021 Q4
4 quarters
CLLS
5971
Cellectis
CLLS
$141M
$3K ﹤0.01%
1,598
+248
+18% +$562
2020 Q1
11 quarters
CTMX icon
5972
CytomX Therapeutics
CTMX
$551M
$3K ﹤0.01%
1,730
-2,672
-61% -$3.95K
2016 Q4
24 quarters
CVAC
5973
DELISTED
CureVac
CVAC
$3K ﹤0.01%
418
-10,955
-96% -$80.9K
2020 Q4
8 quarters
DCGO icon
5974
CALL
DocGo
DCGO
$37M
$3K ﹤0.01%
+400
New +$3.35K
2022 Q4
0 quarters
DUST icon
5975
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$107M
$3K ﹤0.01%
2
-4
-67% -$7.6K
2022 Q3
1 quarter

Similar funds

JP Morgan Chase's Q4 2022 Portfolio in Review

As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
  • JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
  • JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
  • JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
  • JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
  • JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
  • JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.